Skip to main content

Jeffrey Schleutker Comment On Regulatory Notice 22-08

Jeffrey Schleutker
N/A

I strongly oppose any attempt to limit the right to invest in products identified as leveraged, inverse or other investments designed to seek enhanced returns.
These investment products should not just be limited to "privileged" parties but should remain in the public domain available to all investors.
ANY means tests to purchase or invest in these funds should not be required.